These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 33347002)
1. Efficacy and Safety of a Novel Botulinum Toxin A for Masseter Reduction: A Randomized, Double-Blind, Placebo-Controlled, Optimal Dose-Finding Study. Hong JY; Jeong GJ; Kwon TR; Kim JH; Li K; Kim BJ Dermatol Surg; 2021 Jan; 47(1):e5-e9. PubMed ID: 33347002 [TBL] [Abstract][Full Text] [Related]
2. Classification of masseter hypertrophy for tailored botulinum toxin type A treatment. Xie Y; Zhou J; Li H; Cheng C; Herrler T; Li Q Plast Reconstr Surg; 2014 Aug; 134(2):209e-218e. PubMed ID: 25068343 [TBL] [Abstract][Full Text] [Related]
3. RimabotulinumtoxinB versus OnabotulinumtoxinA in the treatment of masseter hypertrophy: a 24-week double-blind randomized split-face study. Lee DH; Jin SP; Cho S; Feneran A; Youn CS; Won CH; Park GH; Kim BW; An J; Chang SE; Lee MW Dermatology; 2013; 226(3):227-32. PubMed ID: 23774030 [TBL] [Abstract][Full Text] [Related]
4. Efficacy of Botulinum Toxin in Treating Asian Indian Patients with Masseter Hypertrophy: A 4-Year Follow-Up Study. Shome D; Khare S; Kapoor R Plast Reconstr Surg; 2019 Sep; 144(3):390e-396e. PubMed ID: 31461011 [TBL] [Abstract][Full Text] [Related]
5. A Multicenter Phase II Study Evaluating the Safety and Efficacy of Botulax in Asian Patients with Benign Masseteric Hypertrophy. Lee JS; Son HS; Kim BJ; Lee YW Plast Reconstr Surg; 2024 May; 153(5):910e-918e. PubMed ID: 37335589 [TBL] [Abstract][Full Text] [Related]
6. [Quantitative analysis based on three-dimensional stereophotogrammetry in the observation of curative effect of botulinum toxin A on masseter hypertrophy]. Xue Z; Zeng W; Chen Z; Han Y Zhonghua Zheng Xing Wai Ke Za Zhi; 2016 Jul; 32(4):272-5. PubMed ID: 30044570 [TBL] [Abstract][Full Text] [Related]
7. Efficacy and Safety of PrabotulinumtoxinA in Subjects With Benign Masseteric Hypertrophy: A Double-Blind, Randomized, Placebo-Controlled, Multicenter, Phase 3 Trial and Open-Label Extension Study. Seok J; Koh YG; Hong JK; Yun SH; Kim DH; Son HS; Choi SY; Yoo KH; Lee YW; Kim BJ Dermatol Surg; 2024 Jun; 50(6):527-533. PubMed ID: 38518110 [TBL] [Abstract][Full Text] [Related]
8. Effects of botulinum toxin type A on contouring of the lower face. Choe SW; Cho WI; Lee CK; Seo SJ Dermatol Surg; 2005 May; 31(5):502-7; discussion 507-8. PubMed ID: 15962731 [TBL] [Abstract][Full Text] [Related]
9. The efficacy of two formulations of botulinum toxin type A for masseter reduction: a split-face comparison study. Wanitphakdeedecha R; Ungaksornpairote C; Kaewkes A; Sathaworawong A; Lektrakul N; Manuskiatti W J Dermatolog Treat; 2017 Aug; 28(5):443-446. PubMed ID: 27884065 [TBL] [Abstract][Full Text] [Related]
10. Lower facial remodeling with botulinum toxin type A for the treatment of masseter hypertrophy. Klein FH; Brenner FM; Sato MS; Robert FM; Helmer KA An Bras Dermatol; 2014; 89(6):878-84. PubMed ID: 25387491 [TBL] [Abstract][Full Text] [Related]
11. A pilot study comparing the efficacy of two formulations of botulinum toxin type A for muscular calves contouring. Wanitphakdeedecha R; Ungaksornpairote C; Kaewkes A; Sathaworawong A; Vanadurongwan B; Lektrakul N J Cosmet Dermatol; 2018 Dec; 17(6):984-990. PubMed ID: 30203534 [TBL] [Abstract][Full Text] [Related]
12. Botulinum toxin type A treatment for contouring of the lower face. Park MY; Ahn KY; Jung DS Dermatol Surg; 2003 May; 29(5):477-83; discussion 483. PubMed ID: 12752514 [TBL] [Abstract][Full Text] [Related]
13. [Noninvasive monitoring of changes in the structure and function of masseter muscles after the injection of botulinum toxin type A]. Guo Z; Diao X; Xia W; Liu T; Chen Y; Zheng J; Zhou Z; Yang P; Zhu J Zhonghua Zheng Xing Wai Ke Za Zhi; 2016 Nov; 32(6):437-40. PubMed ID: 30067323 [TBL] [Abstract][Full Text] [Related]
14. Does Botulinum Toxin Injection into Masseter Muscles Affect Subcutaneous Thickness? Park G; Choi YC; Bae JH; Kim ST Aesthet Surg J; 2018 Feb; 38(2):192-198. PubMed ID: 29117291 [TBL] [Abstract][Full Text] [Related]
15. An Ultrasonographic Analysis of the Deep Inferior Tendon in the Masseter Muscle: Implications for Botulinum Toxin Injections. Shi J; Li C; Zhou J; Guo X; Li G; You M Toxins (Basel); 2024 Sep; 16(9):. PubMed ID: 39330849 [TBL] [Abstract][Full Text] [Related]
16. Three-dimensional CT might be a potential evaluation modality in correction of asymmetrical masseter muscle hypertrophy by botulinum toxin injection. No YA; Ahn BH; Kim BJ; Kim MN; Hong CK J Cosmet Laser Ther; 2016; 18(2):113-5. PubMed ID: 26073120 [TBL] [Abstract][Full Text] [Related]
18. Botulinum toxin for masseter hypertrophy. Al-Muharraqi MA; Fedorowicz Z; Al Bareeq J; Al Bareeq R; Nasser M Cochrane Database Syst Rev; 2009 Jan; (1):CD007510. PubMed ID: 19160335 [TBL] [Abstract][Full Text] [Related]
19. Effects of botulinum toxin type A on bilateral masseteric hypertrophy evaluated with computed tomographic measurement. Kim HJ; Yum KW; Lee SS; Heo MS; Seo K Dermatol Surg; 2003 May; 29(5):484-9. PubMed ID: 12752515 [TBL] [Abstract][Full Text] [Related]
20. Abobotulinum toxin A and onabotulinum toxin A for masseteric hypertrophy: a split-face study in 25 Korean patients. Lee SH; Wee SH; Kim HJ; Yeo UC; Lee NH; Lee SW; Cho SB J Dermatolog Treat; 2013 Apr; 24(2):133-6. PubMed ID: 21888570 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]